BioCanRx and partners announce $6.5M in funding for three new projects including a clinical trial
BioCanRx and its partners announce $6,559,857 in funding for three collaborative research projects including a clinical trial that will have five sites throughout Canada. These novel therapies projects come out of the latest round of full applications.
Moving from the lab to the clinic
It’s one thing to be known among your friends for your famous boeuf bourguignon recipe. It’s another thing entirely to open your own restaurant based on that recipe.
BioCanRx, and partners, announce funding to manufacture first made-in-Canada CAR-T cells
CAR-Ts are a powerful new tool for treating cancer and have begun to provide hope to patients without other therapeutic options to treat and cure their disease.